Patent directory · USPTO A61K / A61P
Patents matching “BOARD OF REGENTS”
2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10179142
Treatment and/or prevention of bone metastasis
granted -
US 10174077
Method of inhibiting activity of cell surface fibroblast activation protein alpha
granted -
US 10172976
Muscle cell patches and uses therefor
granted -
US 10172908
Method for treating cognitive dysfunction
granted -
US 10172827
Pro-neurogenic compounds
granted -
US 10168337
Method and biomarkers for the detection of dengue hemorrhagic fever
granted -
US 10167259
Allosteric inhibitors of proteasome and methods of use thereof
granted -
US 10167337
Combination immunotherapy for the treatment of cancer
granted -
US 10159765
Tissue engineered devices and methods for making same
granted -
US 10155789
Substrates and inhibitors of prolyl oligopeptidase and methods of use thereof
granted -
US 10154881
Methods and compositions for tissue adhesives
granted -
US 10154669
Improving color and release profile of resin compositions comprising silver nanoparticles
granted -
US 10155003
Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer
granted -
US 10151756
Predictive markers for polyamine inhibitor cancer therapies
granted -
US 10150753
Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyrdin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide
granted -
US 10149836
Isoxazole treatments for frontotemporal dementia
granted -
US 10144767
Anti-microbial peptides and coatings
granted -
US 10143658
Multistage delivery of active agents
granted -
US 10126309
Method for the detection of an albumin isoform
granted -
US 10125193
Chimeric antigen receptors and methods of making
granted -
US 10125105
Triazabutadienes as cleavable cross-linkers
granted -
US 10125167
Compositions and methods for treating MRSA infections and for sensitizing MRSA to beta-lactam antibiotics
granted -
US 10125128
GLS1 inhibitors for treating disease
granted -
US 10119140
Methods for enhancing or decreasing the levels of MIR124 and MIR29 in subjects with muscular dystrophy
granted